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Viral detection and identification 
in 20 min by rapid single‑particle 
fluorescence in‑situ hybridization 
of viral RNA
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The increasing risk from viral outbreaks such as the ongoing COVID‑19 pandemic exacerbates the 
need for rapid, affordable and sensitive methods for virus detection, identification and quantification; 
however, existing methods for detecting virus particles in biological samples usually depend 
on multistep protocols that take considerable time to yield a result. Here, we introduce a rapid 
fluorescence in situ hybridization (FISH) protocol capable of detecting influenza virus, avian infectious 
bronchitis virus and SARS‑CoV‑2 specifically and quantitatively in approximately 20 min, in virus 
cultures, combined nasal and throat swabs with added virus and likely patient samples without 
previous purification. This fast and facile workflow can be adapted both as a lab technique and a future 
diagnostic tool in enveloped viruses with an accessible genome.
With over 200 million confirmed cases so far, COVID-19 is the most devastating worldwide pandemic since 
the Spanish Flu of  19181–3. As a respiratory infection caused by the coronavirus SARS-CoV-2, it first surfaced in 
China in late 2019 and has since resulted in over 4 million deaths worldwide. Contact tracing and rapid testing 
have been important tools to limit the spread of disease among the human population.
Currently, the most common diagnostic tests for a SARS-CoV-2 infection are based on nucleic acid ampli-
fication, antigen detection and serology  tests4. Due to its high sensitivity and specificity, reverse transcriptase-
mediated polymerase chain reaction (RT-PCR) represents the gold standard in SARS-CoV-2 testing. However, 
an RT-PCR test takes several hours to complete, and can only be performed in a laboratory setting, as it requires 
viral lysis and RNA purification procedures and therefore sample collection, transportation and reception. 
This routine commonly delays test results by 24 h or more. As a promising alternative to RT-PCR, isothermal 
nucleic acid amplification methods such as loop-mediated isothermal amplification (LAMP) usually yield results 
within 1  h5–11. However, both RT-PCR and LAMP testing have been compromised by supply chain issues due 
to expensive production and storage conditions of the required reagents. Rapid antigen-detection tests based 
on immunoassays and lateral flow formats have been developed to detect SARS-CoV-2, but these can suffer 
from low  sensitivities12. Thus, alternative testing methods that yield quick results with low material costs are 
still urgently needed.
Fluorescence in situ hybridization (FISH) is a cytological technique that exploits the selective binding of 
fluorescently labeled oligo- and poly-nucleotides (20–20,000 nucleotides) to complementary sections of DNA 
and RNA inside fixed cells and tissues for the purpose of detection, quantification and spatial localization by a 
fluorescence microscope. In a medical context, FISH has predominantly been used to detect chromosomal aber-
rations and rearrangements in fixed cells, including translations, insertions and  deletions13–16. FISH has been used 
to detect and identify pathogenic microbes, including  bacteria17,18 and viral infections, e.g. HIV, Epstein-Barr 
virus and Dengue inside infected  cells19–22.
RNA FISH has been used extensively to visualize gene transcription in situ23,24. By increasing the number 
of fluorophores that bind one RNA transcript, detection of single transcripts became possible, giving rise to 
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single molecule FISH (smFISH)25,26. Typical smFISH applications use an array of fluorescently labelled DNA 
oligonucleotides (probes) that bind to several sites on the viral genome, thereby accumulating several fluorescent 
dye molecules on a viral RNA, making it visible as a bright, diffraction-limited spot, while unspecific binding 
to the surface will lead to a darker background of single probes. Further, by utilizing smFISH probes that carry 
spectrally distinct fluorophores, more than one RNA species can be imaged  simultaneously27. In virology, single 
viral genomes or gene segments can be detected by smFISH leading to new insights into the molecular mecha-
nism of infection, replication and assembly of influenza  viruses28–30. Similar studies have been performed in 
other viruses, e.g., rotavirus, bunyavirus and human leukaemia  virus31–33. Importantly, isolated virus particles 
can also be visualized by  smFISH34.
Using smFISH, single viral RNA molecules can be detected without the need for enzymatic amplification. 
However, typical FISH assay times still take several hours to an entire  day35. By increasing the concentrations of 
FISH probes and optimizing fixation conditions, RNA FISH hybridization times could be reduced to 5  min36. 
Moreover, choosing target sequences that do not form secondary structures can greatly increase hybridization 
 rates37.
In this study, we introduce a rapid viral FISH protocol (rvFISH) for the detection of virus particles; the 
development of this improved assay depended on a systematic analysis of the efficiency of the hybridization 
reaction as we reduced the number of experimental steps and the hybridization time. We were able to detect 
influenza particles and infectious bronchitis virus (IBV), an avian coronavirus, down to a concentration of  105 
PFU/ mL and  102 PFU/ mL, respectively, in a 20-min assay. Further, we demonstrated that inactivated SARS-
CoV-2 particles could be detected in the same way. Moreover, we showed that virus particles could be detected 
in nasopharyngeal swabs. By employing a dual-labeling strategy, we were able to suppress background caused 
by misidentified bright, fluorescent spots. Taken together, our data suggest that smFISH can be used as a power-
ful means to quickly and easily detect, identify and quantify a wide range of virus strains in both research and 
diagnostic applications.
Results
Development of a rapid viral FISH protocol for virus detection. As a starting point, we character-
ized the labelling efficiency of an existing RNA FISH protocol for staining viral RNA in the context of virus 
 particles35 (Fig.  1A). In this standard protocol, which takes ~ 4  h to complete, influenza virus particles were 
immobilized by evaporating the virus sample on a plasma-cleaned glass coverslip at room temperature. The virus 
particles were then fixed and the viral membrane was permeabilized to allow the probes to access the genome 
within. An array of fluorescently labelled DNA probes was hybridized to the specific target RNA, followed by 
several washing steps.
In our FISH setup, we applied a 20 µL of sample to a surface area of ~ 3 ×  107 µm2. For instance, a virus sample 
with a concentration of  106 plaque forming units (PFU)/mL would contain 20,000 PFU. Out of the total surface, 
Figure 1.  Efficiency of FISH in free virus particles. (A) Schematic depiction and summary of the standard 
FISH based virus detection protocol with incubation times for the individual  steps35. (B) Representative field of 
view with influenza A/WSN/33 virus particles  (106 PFU/mL) stained by an array of 48 fluorescent hybridization 
probes. Red boxes: Diffraction-limited, isolated particles that were analyzed by stepwise photobleaching. Scale 
bar 3 µm. (C) Representative photobleaching curve recorded to determine the average number of probes bound 
to a virus particle. Arrow: Final bleaching step used to determine the average intensity of a single probe in a 
particle. (D) Intensity distribution of the final bleaching steps of the particles in (B) (red boxes). (E) Scatter plot 
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only an area of ~ 3 ×  105 µm2 was imaged, which would result in the detection of 200 PFU. However, the total 
number of virus particles is known to typically exceed the PFU by orders of magnitude, depending on the virus 
 strain38,39.
To determine the labeling efficiency of this standard viral smFISH protocol, we calculated the number of 
probes bound to the neuraminidase (NA) gene of the influenza virus strain A/WSN/1933 (WSN). To achieve 
this, we immobilized the virus particles, stained them using a Quasar570-labelled FISH probe array comprising 
48 individual 20-nucleotide (nt) probes (Table S1), and used a single-molecule TIRF microscope to image the 
particles (Fig. 1B) and count the bound FISH probes by stepwise photobleaching (Fig. 1C). By averaging the 
decrease in fluorescence intensity of the last bleaching step over several molecules, we determined the average 
fluorescence intensity corresponding to the single fluorophore of an individual FISH probe bound to a virus 
particle (Fig. 1C,D). The initial fluorescence intensities of the particles were then divided by the intensity of a 
single probe to yield the number of probes per particle (Fig. 1D). We found that the 48 targets on the NA segment 
were bound by an average of 45 FISH probes, translating to a very high binding efficiency (~ 95%).
We then drastically shortened the protocol from ~ 4 h to 20 min (Fig. 2A) and evaluated the efficiency of the 
rapid viral FISH protocol. We optimized the conditions to a) achieve rapid and efficient immobilization of virus 
particles, b) reduce the hybridization time to a minimum and c) reduce the number of protocol steps. To enhance 
virus immobilization, the evaporation temperature was increased to 50 °C; at this temperature, a 20 µL sample 
took 10 min to evaporate, compared to 30 min in the standard protocol at room temperature. If the evaporation 
temperature was too high, e.g. 100 °C, the FISH signal was drastically reduced or absent. Evaporation was the 
most efficient method of immobilization, while interaction-based methods, e.g. PEG-Biotin, resulted in lower 
particle counts. Coating the glass surface with poly-l-lysine or chitosan did not increase the immobilization 
count, while occasionally resulting in a higher background from single probes. To reduce the hybridization time, 
we first considered that our results (Fig. 1) indicate that the hybridization conditions of the standard protocol 
result in a near-complete occupation of target sequences in isolated virus particles; this indicated that there 
should be conditions with decreased incubation time that should still provide high hybridization efficiency. 
Indeed, we found that after 10 min, ~ 80% of the targets in a virus particle were occupied, enough to detect it with 
good accuracy. Regarding the reduction in the number of steps, we eliminated the blocking, fixation, clearing and 
most of the washing steps (Fig. 1A), as they did not substantially enhance the detection of isolated virus particles. 
However, it was necessary to wash once with 2 × Saline Sodium Citrate (SSC) buffer after the immobilization to 
remove dried salts and media that interfered with FISH, as well as once with 2 × SSC after hybridization to remove 
the bright fluorescent background of the probes in solution. The permeabilization and hybridization steps were 
combined by adding 0.25% Triton-X100 to the hybridization buffer.
Both the standard and rapid protocols gave rise to specific fluorescence signals on the surface, compared 
to a no-virus control (Fig. 2B), suggesting that the rvFISH protocol still allowed efficient staining of virus par-
ticles. We generated distinct intensity distributions for the detected fluorescent spots in both positive sample 
and negative control data sets (Fig. 2C). While negative samples showed a single distribution at low intensities, 
positive samples tended to result in bimodal distributions; these bimodal distributions included a low-intensity 
distribution (with a peak at ~ 1500 AU), which represents single probes and unspecific probe aggregates, and a 
high-intensity distribution (with a peaks at ~ 35,000 AU for rvFISH and ~ 55,000 AU for standard FISH), which 
is caused by FISH-stained virus particles (Fig. 3B). By comparing the mean fluorescence intensities of particles 
Figure 2.  Efficiency of the rapid FISH protocol for virus detection. (A) Schematic depiction and summary of 
the rapid virus detection FISH protocol with incubation times. WSN particles were stained with FISH probes 
against WSN. (B) Comparison of FISH protocols. Top row: Standard protocol (see Fig. 1A). Bottom row: 
rvFISH (see A). Left panels: WSN particles at concentration of  106 PFU/mL35, hybridization time 1 h. Right 
panels: FISH staining (Fig. 1B) in the absence of virus. Scale bar 10 µm. (C) Intensity distributions of fluorescent 
spots detected in the samples in (B) Top: standard protocol, bottom: rvFISH protocol. (D) Average particle 
intensity comparison of protocols in (B). std: standard protocol, rapid: rvFISH protocol. Error bars: standard 
deviation (SD) of particle intensity.
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Figure 3.  Performance of the rapid viral FISH protocol on virus culture supernatants of WSN and IBV 
in 0.9% NaCl. (A) Images of FISH-stained WSN (top panel,  106 PFU/mL) and IBV (mid panel,  104 PFU/
mL). Left column: complementary FISH probe set, Right column: non-complementary FISH probe set as a 
negative control: IBV for WSN, WSN for IBV. Arrow: Bright fluorescent spot in the negative sample that will 
be recognized as a virus particle. Scale bar: 10 µm. (B) Intensity distributions of fluorescent spots detected in 
the samples in A. Top: WSN, bottom: IBV. Grey area: correct FISH probe set, black line: control FISH probe set 
(see A). (C) Limit of detection (LOD) of FISH protocol for dilutions of virus culture supernatants in 0.9% NaCl. 
Left: Particle counts for an influenza sample. influenza probes (grey, +), IBV probes (white, -). Right: Particle 
counts for an IBV sample. IBV probes (grey, +), influenza probes (white, -), bottom panels: dilutions (PFU/mL), 
STD: standard protocol at  106 PFU/mL, error bars: SD of three independent experiments, *T-test, p < 0.05. (D) 
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over 20,000 AU for the standard and rapid protocols, we found that the labelling efficiency of the rapid protocol 
was ~ 80% of the standard protocol (Fig. 2D). This suggests that particles are bound by a sufficient number of 
probes to make them easily distinguishable from probes randomly bound to the surface in the absence of virus 
(Fig. 2B, right panel and Fig. 2C).
Detection of coronavirus using rapid RNA‑FISH. Next, we determined whether the rvFISH assay 
could be used to detect coronavirus particles. We designed Quasar570-labelled probe arrays for the avian coro-
navirus (CoV) infectious bronchitis virus (IBV), comprising 32 individual 20-nt DNA probes (Table S2). The 
probes targeted the nsp12 segment, encoding for RNA-dependent RNA polymerase (RdRP). We performed the 
rvFISH protocol on cultured influenza WSN strain (3.3 ×  108 plaque forming units (PFU)/mL) and IBV  (106 
PFU/mL). For both stocks, experiments were performed and tested using the complementary FISH probe array 
(positive sample) and an array that targeted one of the other two stocks (negative control). We obtained bright 
signals for both virus strains when the complementary FISH probe sets were used; in contrast, we obtained only 
low or no background in the presence of the non-complementary probes (Fig. 3A), indicating that our labelling 
was specific.
We also generated distinct intensity distributions for the detected fluorescent spots in both positive sample 
and negative control data sets (Fig. 3B). While negative samples with the non-complementary probe sets showed 
a single distribution at low intensities, positive samples with the complementary probe set tended to result in 
bimodal distributions, similar to the virus-negative and positive samples in Fig. 2C. This was the case for both 
the WSN and IBV virus sample, illustrating that both WSN and IBV can be detected with the rvFISH assay.
Determining the limit of detection for influenza and coronaviruses. Next, we determined the 
detection limit of the rvFISH assay from the fluorescence intensity distributions. To quantify the number of 
particles, we corrected their intensities for day-to-day fluctuations in laser power (about ± 20%) by normalizing 
them to the approximate intensity value of a single fluorophore, given by the median intensity value of the nega-
tive sample with the lowest virus concentration. Spots within an intensity range of 15–40 single fluorophores 
were counted as particles. While particles were present in both positive and negative samples, the number of 
detected particles was significantly higher (T-test, p < 0.05) in positive samples down to a concentration of  105 
PFU/ mL for WSN and  102 PFU/ mL for IBV (Fig. 3C,D). A direct comparison of rvFISH and the standard 
protocol at  106 PFU/mL demonstrates that virus particles are detected with the same efficiency (Fig. 3C). The 
detection sensitivity was limited by bright fluorescent spots occurring in the negative samples that were falsely 
identified as virus particles (Fig. 3A, top right, arrow). Typically, a negative sample consisting of 81 fields of view 
(FOVs) had ~ 100 such spots, and their number slightly increased with higher virus concentrations. These spots 
are most likely caused by FISH probe aggregates in the hybridization solution and several probe molecules non-
specifically binding to distinct locations on the surface, and will subsequently be referred to as ‘noise’. The inten-
sity distribution of bright spots in a negative sample is different from the virus samples in that the particle counts 
are continuously decreasing with higher intensities (Fig. 3B). Overall, however, our limit of detection (LOD) was 
in a comparable range to that of other diagnostic tests, such as RT-PCR (LOD ~  102 RNA copies/ mL)40 or lateral 
flow assays (LOD ~  102 PFU/ mL for SARS-CoV-2)41.
Detection of SARS‑CoV‑2 using rapid RNA‑FISH. To demonstrate that the rvFISH assay was capable 
of detecting SARS-CoV-2, we designed a 41-probe FISH array targeting the nsp12 segment (Table S3), analo-
gous to the IBV probe set. The FISH protocol was performed on cultured SARS-CoV-2  (106 PFU/ mL) that was 
diluted to  104 PFU/mL. Similar to WSN and IBV, a high number of bright particles was only seen in the pres-
ence of the SARS-CoV-2 probes (Fig. 4A). Moreover, an IBV sample with SARS-CoV-2 probes had the same 
low number of bright spots as other negative samples, underlining the probe set specificity (Fig. 3A, bottom 
right). The correct probe set resulted in a bimodal distribution, similar to WSN and IBV (Fig. 4B). However, 
Figure 4.  Performance of the virus detection FISH protocol on a virus culture supernatant of SARS-CoV-2 in 
0.9% NaCl. (A) Images of FISH-stained SARS-CoV-2  (104 PFU/mL). Left: SARS-CoV-2 FISH probe set, right: 
IBV probe set as a negative control. Scale bar 10 µm. (B) Intensity distributions of fluorescent spots detected 
in the samples in (A). Grey area: complementary FISH probe set, black line: negative control FISH probe set, 
dotted line: IBV sample with IBV probes (Fig. 3B, bottom) for comparison. (C) Comparison of rvFISH particle 
counts of SARS-CoV-2 and IBV (both  104 PFU/mL). SC2: SARS-CoV-2. Complementary probes (grey, +), non-
complementary probes (white, -).
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SARS-CoV-2 particles were generally not as bright as IBV particles, despite the higher number of probes in a 
SARS-CoV-2 FISH array (44 vs. 32), perhaps because SARS-CoV-2 was inactivated in 4% formaldehyde before 
use; formaldehyde has been shown to decrease the probe binding efficiency to mammalian cells in a previously 
established rapid FISH  protocol36. Nevertheless, a direct comparison of the particle counts for IBV and SARS-
CoV-2 at  104 PFU/mL shows a similar detection efficiency (Fig. 4C). Together with the LOD for IBV, this result 
suggests that the assay could be developed into a clinically relevant diagnostic test.
Dual‑color rapid FISH to increase the assay specificity and suppress noise. As the detection sen-
sitivity was limited by non-specific noise, we examined the possibility of noise reduction by staining WSN par-
ticles with two sets of WSN probes carrying spectrally distinct fluorophores. For this purpose, we split the WSN 
probe array described above into two separate arrays that were labeled with Quasar570 (green) and Quasar650 
(red), respectively. The probes of both sets bind along the NA segment in an alternating manner (Fig. 5A). In 
the detection assay, we incubated the sample with green probes only and subsequently added the red probes for 
Figure 5.  Increased signal-to-noise ratio with dual-color FISH. (A) Schematic depiction of the NA segment in 
an influenza particle labelled with two probe sets carrying spectrally distinct fluorophores. (B) Representative 
image of a dual-labelled WSN sample. Left column: diluted virus culture supernatant  (106 PFU/mL). Right 
column: equally diluted growth medium (negative control). Top row: composite image (C), middle row: green 
channel (G), bottom row: red channel (R). Scale bar 10 µm. (C) Particle counts in the green, red channel 
and co-localized particle-counts (yellow). Empty columns: virus sample, striped columns: negative control 
(DMEM + 5% FCS), error bars: SD, three independent experiments. (D) The performance of a single-color FISH 
probe set (left) and the dual-color FISH probe set (right) with the same total number of probes is compared 
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another 5 min. This way, all unspecific binding sites should predominantly be occupied by the green probes, 
while the virus particles would be stained with both fluorescent dyes, resulting in co-localized spots in the green 
and the red channel (Fig. 5B). As a negative control, we performed the assay on just the culture medium used 
for virus propagation (Dulbecco’s Minimal Essential Medium + 0.5% foetal calf serum), in the absence of virus 
particles. Spots in both the red and the green channel were analyzed as described above. However, as the total 
number of probes in the array was equal to that of the monochromatic probe set used earlier, 50% less probe 
binding was expected. Hence, spots with an intensity of 5–20 green fluorophores and 3–20 red fluorophores were 
counted as particles in the green and red channel, respectively. We found a signal-to-noise ratio (SNR) (Fig. 5C) 
similar to the single-color probe array (Fig. 4A). However, when we only counted the particles that co-localized 
in the green and red channel, the noise was reduced tenfold, while the particle counts in the positive sample were 
only reduced 1.6-fold (Fig. 5C). A direct comparison of the SNR of the correlated spots from Fig. 5C to the per-
formance of a monochromatic probe set of the same size (Fig. 3C) showed a five-fold increase of the SNR when 
using dual-color probe set, although the difference was not statistically significant (T-test, p > 0.05) (Fig. 5D). 
Together, these results suggest that the use of a dual-color probe set can efficiently decrease the LOD in our rapid 
detection assay by a factor of 5.
Performance of the FISH virus detection assay in combined nasal and throat swabs. In order 
to assess whether the rvFISH protocol would work on clinically relevant samples, we simulated virus detection 
in a combined throat and nasal swab. A swab was taken from an apparently healthy individual according to 
instructions published by Public Health England (Fig. 6A)42. To determine how the throat swab medium and 
any biological material from the patient affects the detection limit, we serially diluted the swab with 0.9% NaCl. 
To directly compare the particle counts, we added IBV to a final concentration of  104 PFU/mL in all samples, a 
concentration that represents a compromise between a high number of detected virus particles and low noise. 
All samples were clarified by centrifugation and the rvFISH protocol was performed on them as described above. 
Additionally to IBV probes (Fig. 6B, “ + ”), we incubated the samples with SARS-CoV-2 probes as a negative con-
trol (“−”). In an undiluted throat swab, the particle count was drastically reduced and indistinguishable from the 
particle count of a negative sample (Fig. 6B). For samples containing less throat swab material (diluted by 1:10, 
1:100 and 1:1000), the particle count rose to up to ~ 80% of the count obtained in the saline solution (Fig. 6B), 
indicating that diluting the throat swab material increases the overall sensitivity of the assay. However, as the 
dilution lowers the virus concentration, virus in throat swabs would best be detected by diluting the swabs as 
little as possible, as e.g., a 1:10 dilution would result in a detection efficiency of 0.1 × 23% = 2.3%, while a 1:100 
dilution will only have an efficiency of 0.01 × 59 = 0.59%, etc. We conclude that the rvFISH assay will work on 
diluted clinical swab samples without purification, and suggest that material of non-viral origin in the swab, e.g., 
cellular debris and transfer medium ingredients, increases the LOD by about 1.5–2 orders of magnitude.
We then investigated whether rvFISH was able to detect virus particles inside clinical samples despite the 
apparently reduced sensitivity in swabs. For this purpose, we examined three SARS-CoV-2 positive and three 
negative previously inactivated clinical throat swabs that were clarified by centrifugation and diluted 1:10 in viral 
resuspension buffer before going through the rvFISH protocol. In the presence of complementary probes, two 
out of three positive samples, SC1  (Ct = 24) and SC2  (Ct = 27), showed elevated particle counts when compared 
to the negative samples (Fig. 6C). Notably, SC3, the sample with the lowest Ct (17) and therefore the highest 
concentration according to PCR, showed no elevated particle count over the negative samples. This discrepancy 
might be caused by stability issues of the virus particles in some samples during inactivation and transport or 
by additional complexity in the nature of the samples (composition of the swab material, status of the infection 
etc.). When non-complementary probes were used for FISH-positive SC2, the particle counts were not increased 
in comparison to a negative sample (N1). This indicates that the majority of counts in SC1 and SC2 are from 
SARS-CoV-2 particles, and provides evidence for the detection of SARS-CoV-2 by rvFISH.
Discussion
In this study, we explored the possibility of using a rapid FISH protocol for the detection of virus particles in 
culture supernatants and clinical samples. Using our protocol, we were able to detect influenza and coronavirus 
particles within 20 min after a sample is taken, substantially quicker than current RT-PCR protocols, while 
involving fewer protocol steps for sample  purification43; our results open up the possibility of using FISH for 
real-time diagnosis and detection of virus infections. Moreover, our assay can be developed to rapidly measure 
virus titers in a virology lab, e.g. when biotechnological applications require a timely determination of the par-
ticle concentration in a virus culture. Direct comparison of the particle number determined by the FISH assay 
to the results from plaque assays can be used to determine the PFU-to-particle ratio, an important measure for 
the infectivity of a virus  sample39.
By focusing on the detection of RNA inside free virus particles as compared to viral RNA inside infected host 
cells, we were able to drastically simplify an existing smFISH protocol. Hence, it is unlikely that rvFISH works 
with the same efficiency and specificity in more complex biological samples like infected cell cultures or tissues. 
Further, we found that the particle count is drastically reduced in undiluted throat and nasal swabs, most likely 
because the medium and swab material negatively affected the particle immobilization by evaporation (Fig. 6B). 
Nevertheless, rvFISH was capable of detecting SARS-CoV-2 in inactivated clinical samples (Fig. 6C).
The current speed of detection is mainly limited by the evaporation time of the sample during immobiliza-
tion and by the hybridization rate at the given probe concentration; to reduce the evaporation time of the virus 
sample, the temperature can be increased to above 50 °C. However, higher temperatures interfere with the FISH 
assay, through impacting either the stability of the viral RNA or the structure of the virus particles themselves, 
making them less likely to attach to the surface. Alternatively, a vacuum can be used to increase the evaporation 
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rate, but might lead to increased technical requirements. A third solution involves passing the virus solution 
through a filter that retains virus particles and subsequently imaging the filter residue.
Regarding the hybridization time, previous rapid FISH protocols have demonstrated that probe concentra-
tions of > 100 µM can be used in eukaryotic cells, compared to 1 µM of probes used in our rapid smFISH  assay36. 
Assuming that the hybridization rate increases linearly to probe concentration, we expect that the hybridization 
step can be further reduced to under 1 min.
During the current COVID-19 pandemic, it became obvious that the need for SARS-CoV-2 testing exceeded 
the capacities of the biomedical sector and the biotech industry, and shortages  occurred44,45. FISH only uses fluo-
rescent oligonucleotides and widely available lab chemicals that can be stored at room temperature, while other 
Figure 6.  Efficiency of virus detection in a throat swab. (A) Combined nasal and throat swabs were taken 
according to WHO  instructions42. Subsequently, the throat swabs were diluted in saline and spiked with the 
same concentration of IBV  (104 PFU/mL) in each sample. After a centrifugation step, virus particles were 
immobilized and FISH stained as described. (B) Efficiency of virus detection in throat swabs compared to virus 
diluted with saline, dependent on the dilution factor. [+]: IBV probes, [–]: SARS-CoV-2 probes, U: undiluted, 
error bars: SD of three independent experiments. (C) Mean particle counts of clinical samples analyzed by 
rvFISH using complementary (grey bars, ‘probes + ’) and non-complementary (white bars, ‘probes –’) probes. 
SC1–3: SARS-CoV-2 positive samples. N1–3: SARS-CoV-2 negative clinical samples. Error bars: standard 
deviation of two independent experiments.
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detection methods additionally require more precious and sensitive biomolecules like enzymes, antibodies etc. 
Apart from E. coli tRNA, which can probably be replaced by a more durable blocking agent, all used materials 
can be stored at room temperature in dried form. The favourable storage conditions make our assay a possible 
candidate for field use, e.g. in the context of emerging pathogens, while the independence of enzymatic reac-
tions can open new experimental avenues, in sample conditions and analysis protocols where specific enzymes 
may not work.
The LOD was defined as the lowest tested virus concentration with statistically significant difference (T-test, 
p < 0.05) between a sample with a complementary probe set and a sample with a non-complementary control 
probe set. The LOD of our assay was  105 PFU/mL for WSN and  102 PFU/mL for IBV, comparable to the most 
sensitive lateral flow assays (LOD ~  102 PFU/ mL for SARS-CoV-2)41. The discrepancy in LOD between the two 
virus strains can be explained by the observation that in general, not more than one in 10,000 cultured coronavi-
rus particles is thought to be infective, while the particle-to-PFU ratio in influenza ranges from 10:1 to 100:138,39. 
Therefore, qRT-PCR with a detection limit of  102 RNA copies/mL can still be considered at least 100 times more 
sensitive than our assay in its current form. However, not all RNA molecules in a virus sample might be accessible 
to PCR amplification, a scenario that is less likely for the binding of multiple FISH probes to an RNA target. To 
further lower the LOD of the rvFISH assay, the number of false-positive particles from fluorescent noise needs 
to be reduced, while the sampled area needs to be increased.
Regarding the reduction of false positives in the negative control, we note that, in our FISH data, we usually 
discovered ~ 1 bright fluorescent spot per FOV that was identified as a virus particle by the detection algorithm, 
thereby limiting the sensitivity of our assay. We also demonstrated the success of a dual-color labelling approach, 
which used co-localization analysis to reduce the number of false-positive particles fivefold. The false positives 
can be reduced further by employing both a higher probe concentration and a larger probe array. The rationale 
in using more probes is that in a negative sample, false-positive particles become steadily less frequent at higher 
intensities; if virus particles have more probes bound to them, they will be brighter and therefore better distin-
guishable from most of the noise. Further, in a previous study, we used deep learning to detect virus particles 
in culture supernatants and clinical samples by staining their surface with fluorescent  oligonucleotides46. Here, 
deep learning may be a future option to recognize and eliminate false-positive particles from our FISH analysis.
Regarding the increase of sampled area, we used the difference in particle counts between positive and 
negative samples at an IBV concentration of  102 PFU/ mL to estimate that we could observe ~ 150 particles per 
dataset. This means that the theoretical detection limit in the absence of any noise would be around  100 PFU/ 
mL, as the sampled area will contain less than one particle on average for lower concentrations. However, we 
only sampled an area of 0.33  mm2, compared to the total area of 28  mm2. Thus, sampling the entire area would 
increase the theoretical sensitivity by two orders of magnitude, comparable to RT-PCR. To achieve sampling of 
the total area in a reasonable time frame, the sampling velocity would have to be increased by using an objective 
with lower magnification, e.g., by using an objective with a magnification of 20×, instead of 100×, we can sample 
a 25-fold larger area in the same amount of time. However, depending on the power of the microscope, the use 
of weaker objectives might require enhancing the signal from the virus particles (see previous paragraph) due 
to their lower numerical aperture and light collection efficiency.
A practical limitation for the wide-spread application of our approach is the fact that a fluorescence micro-
scope is required. In this study, we used a commercial instrument capable of detecting fluorescence from single 
molecules, that we used to calibrate the detection limit for virus particles. However, as brighter particles (like 
fluorescent beads) can be used for this calibration, single molecule detection is not a requirement, and virus par-
ticles (which bind ~ 20 probes on average) should already be detectable by less sensitive microscopes. Improving 
particle brightness by expanding the probe arrays would bring down the technical requirements even more, to 
the point where mobile microscopy equipment might be  used47,48. The microscopy skills required from the test-
ing personnel or experimenter can be reduced by automated acquisition, auto-focusing, or having a microscope 
with a fixed axial position.
A second limitation to virus detection by FISH is the accessibility of the viral genome to the hybridization 
probes that is expected to vary with genome architecture. In influenza, the viral RNA is coated by a nucleopro-
tein that associates with RNA, but does not appear to affect the hybridization efficiency noticeably, as our data 
shows (Fig. 1). Even though the nucleocapsid protein of coronaviruses may pose an additional barrier to the 
probes, the rvFISH assay still works with a similar efficiency. However, other enveloped viruses like lentiviruses 
and rhinoviruses possess a rigid protein capsid around their genetic material that may render FISH staining of 
complete virus particles difficult to impossible without substantially altering the protocol.
Apart from potentially detecting a wide range of virus strains, the rvFISH protocol will be a versatile tool to 
design experiments to investigate hybridization of oligonucleotides to virus particles in detail and thus, provide 
a foundation for the optimization of other hybridization-based techniques like PCR and LAMP.
Methods
Virus strains and FISH probe arrays. H1N1 A/WSN/1933 (WSN) influenza and coronavirus IBV have 
been described  previously46,49. Briefly, WSN virus was grown in Madin-Darby bovine kidney (MDBK) cells. The 
cell culture supernatant (Minimal Essential Media, Gibco) was collected and the viruses were titred by plaque 
assay, yielding a virus titre of 3.3 ×  108 plaque forming units (PFU)/mL. IBV (Beau-R strain)50 was grown in 
chicken kidney (CK) cells and titred by plaque assay (1 ×  106 PFU/mL). Viruses were inactivated by addition of 
0.2% formaldehyde before use. SARS-CoV-2 was grown in Vero E6 cells. The cell culture supernatant (Dulbec-
co’s Modified Eagle Medium, Gibco) was collected and titred by plaque assay, yielding a virus titre of 1.05 ×  106 
PFU/mL. The virus was inactivated by addition of 4% formaldehyde before use.
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Stellaris FISH probe arrays were ordered from Biosearch Technologies (Risskov, Denmark). The probes were 
designed using Stellaris’ online design tool, specifying the probe length as 20 nt and the maximum probe number 
per array as 48 (Tables S1–S3). The sequences of the NA segment in WSN and RdRP gene in CoV were selected 
as the target regions for the probes.
Surface preparation. Coverslips (Menzel) were sonicated in 2% Hellmanex for 15 min, rinsed with MilliQ 
water 5 times, sonicated in water for another 5 min, rinsed with water 5 times and dried under an  N2 stream. 
Subsequently, the dried coverslips were cleaned for 30 min in a plasma cleaner (Harrick) at high plasma strength 
for at least 30 min. Silicone gaskets (CultureWell, diameter 6 mm) were placed on the plasma-treated coverslips.
Standard FISH protocol. This protocol is a modified version of a previously described  protocol35. A virus 
stock diluted in 0.5% NaCl was added to a plasma-treated coverslip and evaporated at room temperature and 
washed with phosphate buffered saline (PBS). The immobilized virus was fixed with 4% formaldehyde in PBS for 
10 min and subsequently permeabilized with 0.5% Triton X-100 in PBS for 15 min. After washing with 2 × saline 
sodium citrate (SSC), the surface was blocked with hybridization buffer 1 (HB1; 2 × SSC, 10% formamide, 10% 
dextran sulfate, 0.02% RNase free-BSA, 0.2 mg/ml E. coli tRNA, 1% RNasin Plus (Promega)) for 30 min at 37 °C. 
Subsequently, the sample was incubated with 1 µM FISH probes in HB1 for 1–3 h at 37 °C. After hybridization, 
the sample was cleared with 2 × SSC, 10% formamide, 1% RNasin Plus and washed three times with 2 × SSC.
Rapid FISH protocol. A virus stock diluted in 0.5% NaCl was added to a plasma-treated coverslip and 
evaporated at 50 °C for 10 min and washed with 2 × SSC. The immobilized virus was incubated with 1 µM FISH 
probes in HB2 (2 × SSC, 10% formamide, 0.02% RNase free-BSA, 0.2 mg/ml E.  coli tRNA, 1% RNasin Plus, 
0.25% Triton X-100) for 10 min at 37 °C and washed once with 2 × SSC after hybridization.
Throat swabs. A swab was taken from an apparently healthy individual according to instructions published 
by Public Health  England42. Experiments using throat swab material were performed in accordance with the 
Declaration of Helsinki and approved by the Medical Sciences Interdivisional Research Ethics Committee of the 
University of Oxford (R76273/RE001). Informed consent was obtained from the throat swab donor. The samples 
were clarified by centrifugation at 13,000×g for 5 min prior to use.
Clinical samples. Ethical approval was obtained for the use of anonymized oropharyngeal specimens from 
patients for the diagnosis of SARS-CoV-2 (North West-Greater Manchester South Research Ethics Committee 
[REC], REC Ref:19/NW/0730). Specimens were maintained in Copan Universal Transport Medium (UTM) 
before being inactivated in a 1% final concentration of formaldehyde (Pierce) for 5 min at room  temperature51, 
followed by clarification at 13,000×g for 5–10 min and diluted 1:10 in viral resuspension buffer (10 mM Tris HCl 
pH8, 100 mM NaCl) prior to use.
Imaging conditions. All experiments were performed on a commercially available Nanoimager fluores-
cence microscope (Oxford Nanoimaging). The sample was imaged using total internal reflection fluorescence 
(TIRF) microscopy. The laser illumination was focused at an angle of 54° with respect to the default position. 
Images of a field of view (FOV) measuring 80 × 49 µm were taken with an exposure time of 500 ms, with a laser 
intensity kept constant at 780 kW/cm2 for the green (532 nm) laser when taking single-color images, and at 
624 kW/cm2 for the green laser and 390 kW/cm2 for the red (647 nm) laser, when taking dual-color images. To 
automate the task and ensure no bias in the selection of FOVs, the whole sample was scanned using the multiple 
acquisition capability of the microscope; 81 FOVs were imaged in 3 min. For photobleaching experiments, the 
exposure time was decreased to 100 ms and the laser power (532 nm) was increased to 2.34 mW/cm2.
Data analysis. All microscope data was processed using MatLab2019b. To correct the images for uneven 
illumination, an image was generated from the median pixel values across all FOVs and fitted with a cubic 
smoothing spline (‘csaps’, smoothing parameter =  10–7). The values of the fit were then normalized to the average 
intensity of a pixel and multiplied with the grey values of each raw image. Moreover, the average value of the fit 
was used as the fluorescent background of the images.
To detect fluorescent spots, each image was bandpass filtered (‘bpass’, noise length = 0, object length = 6). 
The median value of all non-zero pixels in the filtered image was multiplied by three and used as a threshold 
to binarize the filtered image. The ‘bwpropfilt’ function was used to exclude objects smaller than 5 pixels (px). 
The intensity-weighted centroids of the remaining regions were calculated from the grey values of the original 
image using the ‘regionprops’ function (Steve Eddins). The intensity of the fluorescent spot was determined as 
the background-subtracted intensity of a bounding box with a diameter of 5 px around the centroid.
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